In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones

Journal of Infection in Developing Countries

Volumn 4, Issue 3, 2010, Pages 164-167

  Rodriguez, Carlos Hernan ^a   de Ambrosio, Alejandra ^b   Bajuk, Milena ^b   Spinozzi, Mariela ^b   Nastro, Marcela ^a   Bombicino, Karina ^a   Radice, Marcela ^b   Gutkind, Gabriel ^b   Vay, Carlos ^a   Famiglietti, Angela ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

A. baumannii; Colistin heteroresistance; Imipenem; Rifampicin; Time kill assay

Indexed keywords

CARBAPENEMASE; COLISTIN; GENTAMICIN; HYDROLASE; IMIPENEM; OXACILLINASE; RIFAMPICIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENDEMIC SPECIES; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII;

EID: 77951175059     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.604     Document Type: Article

References (18)

1. Peleg AY, Seifert H, Paterson D (2008) Acinetobacterbaumannii: Emergence of successful pathogen. ClinMicrobiol Rev 21: 538-92
2. Zarrilli R, Giannouli M, Tomasone F, Triassi M, Tsakris A (2009) Carbapenem resistance in Acinetobacter baumannii:the molecular epidemic features of an emerging problem inhealth care facilities. J Infect Dev Ctries 3: 335-41
3. Li J, Rayner CR, Nation RL, et al. (2006) Heteroresistanceto colistin in multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 50: 2946-50
4. Barbolla RE, Centron D, Di Martino A, et al. (2003) Identification of an epidemic carbapenem-resistantAcinetobacter baumannii strain at hospitals in Buenos Airescity. Diag Microbiol Inf Dis 45: 261-64
5. Merkier A, Catalano M, Ramirez M, Quiroga C, Orman B, Ratier L, Famiglietti A., Vay C, Di Martino A, Kaufmann S, Centron D (2008) Polyclonal spread of blaoxa-58 inAcinetobacter baumannnii isolates from Argentina. J InfectDev Ctries 2: 235-40
6. Rodríguez CH, Juárez J, de Mier C, et al. (2003) Resistenciaa antibióticos de bacilos gram negativos aislados enunidades de cuidados intensivos. Análisis comparativo dedos años (1998-2001). Medicina (Buenos Aires) 63: 21-27
7. Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G, et al. (1995) Identification ofAcinetobacter genomic species by amplified ribosomalDNA restriction analysis. J Clin Microbiol 33:11-15
8. Seirfert H, Dolzani L, Bressan R et al. (2005) Standardization and interlaboratoryreproducibilityassessmentpulsed-fieldelectrophoresisgeneratedfingerprints of Acinetobacter baumannii. J Clin Microbiol43: 4328-35
9. Clinical and Laboratory Standards Institute. (2006) Methodsfor dilution antimicrobial susceptibility test for bacteria thatgrow aerobically. Approved standard M7-A7. Clinical andLaboratory Standards Institute, Wayne PA
10. SFM Antibiogram Committee (2003) Comite del'Antibiogramme de la Société Française de Microbiologiereport. Int J Antimicrob Agents. 21: 364-91
11. Woodford N, Ellington M, Coehlo J, Turton J, Ward M, Brown S, Amyes S, Livermore D (2006) Multiplex PCR forgenes encoding prevalent OXA carbapenemases inAcinetobacter spp. Int J Antimicrob Agents 27: 351-53
12. Lee K, Lim S, Yum JH, Yong D, Chong Y (2003) Evaluation of the Hodge test and the imipenem-EDTAdouble-disk synergy test for differanting metallo-b-lactamase-producing isolates of Pseudomonas spp. andAcinetobacter spp. J Clin Microbiol 41: 4623-29
13. Yoon J, Urban C, Terzian C, Mariano N, Rahan J (2004) Invitro double and triple synergistic activities of polymyxin B,imipenem, and rifampin against multidugr-resistantAcinetobacter baumannii. Antimicrob Agents Chemother 48: 753-57
14. Montero A, Ariza J, Corbella X, Doménech A, Cabellos C, Ayats J, Tubau F, Borraz C, Gudiol (2004) Antibioticcombinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumoniamodel. J Antimicrob Chemother 54: 1085-91
15. Tripodi MF, Durante-Magnoni E, Fortunato R, Utili R, Zarrilli R (2007) Comparative activities of colistin,rifampicin, imipenem and sulbactam-ampicillin alone or incombinationagainstepidemicmultidrug-resistantAcinetobacter baumannii isolates producing OXA-58carbapenemases. Int J Antimicrob Agents 30: 537-40
16. Landman D, Georgescu C, Martin A, Quale J (2008) Polymyxins revisited. Clin Microbiol Rev 21: 449-65
17. Tan T, Ng L, Tan E, Huang G (2007) In vitro effect ofminocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates. JAntimicrob Chemother 60: 421-23
18. Principe L, D'Arezzo S, Capone A, Petrosillo N, Visca P (2009) In vitro activity of tigecycline in combination withvarious antimicrobials against multidrug resistantAcinetobacter baumannii. Ann Clin Microbiol Antimicrob 8: 18.